Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

108.07
-0.4800-0.44%
Pre-market: 107.27-0.8000-0.74%05:21 EDT
Volume:102.96K
Turnover:11.00M
Market Cap:2.08B
PE:-490.23
High:108.34
Open:106.95
Low:104.65
Close:108.55
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 27, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K/A [Amend] - Current report
Dec 03, 2020

Major Issues Report

8-K - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]